Welcome to BioRN

About 80 companies from the field of red biotechnology develop drugs, technology platforms and diagnostics at the Biotech Cluster Rhine-Neckar (BioRN). Globally acting healthcare companies as well as internationally renowned research institutes also play a significant  part in this development.

With its focus on personalized medicine and cancer research the BioRN cluster occupies a leading position in Germany. In 2008 it was awarded the leading-edge cluster for “Cell based and molecular medicine in the Rhine-Neckar Metropolitan Region”


October 28, 2014
Leica Biosystems to Acquire Devicor Medical Products, Inc.
» [more]

October 28, 2014
Apogenix – Positive Results from APG101 Phase II Clinical Trial Published in Clinical Cancer Research
» [more]

October 24, 2014
PEPperPRINT characterizes multiple LRRK2 antibodies for Parkinson’s disease research
» [more]


Read our monthly BioRN Newsletter. It will keep you informed about what´s going on in the BioRN cluster.


» Find further future events here

HAE R&D Community

Increase your chances of getting your R&D project funded